首页> 外文期刊>The European Journal of Neuroscience >Upregulation and axonal transport of synaptotagmin-IV in the direct-pathway medium spiny neurons in hemi-parkinsonian rats induced by dopamine D1 receptor stimulation
【24h】

Upregulation and axonal transport of synaptotagmin-IV in the direct-pathway medium spiny neurons in hemi-parkinsonian rats induced by dopamine D1 receptor stimulation

机译:多巴胺D1受体刺激引起的半帕金森病大鼠直接通路中突棘神经元中突触结合蛋白IV的上调和轴突运输

获取原文
获取原文并翻译 | 示例
           

摘要

Synaptotagmin-IV (Syt-IV) may function as a regulator of Ca2+-dependent synaptic transmission. In the hemi-parkinsonian rats with unilateral lesions of dopaminergic nigrostriatal neurons Syt-IV and substance-P (SP) mRNAs could be upregulated within the dopaminergically hypersensitive striatum of the lesioned brain hemisphere via the stimulation of striatal dopamine D1 (D1-R), but not D2 receptors. The hypersensitive D1-R-mediated transmission may be the culprit for the undesired expression of levodopa-induced dyskinesia, implying the involvement of Syt-IV and SP in the process. First, striatal cellular phenotypes expressing Syt-IV were determined. It was found to be expressed in all striatal neurons and a small population of astrocytes. Then it was examined, if the D1-R-mediated upregulation of Syt-IV mRNA may result in the upregulation of the translated protein. It was found that, after acute stimulation with a selective D1 agonist, (+/-)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide (SKF-82958), Syt-IV was elevated within the SP-expressing striatal neurons of the lesioned side. This was followed by the upregulation of Syt-IV, but not of its mRNA, within the ipsilateral target nuclei of the direct-pathway medium spiny neurons, indicating axonal transport of de novo synthesized protein to their SP-positive synaptic terminals. However, despite the striatal upregulation of SP and Syt-IV following a similar time-course, their subcellular co-localization within the axonal terminals was not found. It was therefore suggested that Syt-IV may regulate the hypersensitive striatal synaptic transmission, although via a SP-independent mechanism.
机译:突触素-IV(Syt-IV)可以作为依赖Ca2 +的突触传递的调节剂。在多巴胺能黑质纹状体神经元单侧损伤的半帕金森病大鼠中,通过刺激纹状体多巴胺D1(D1-R),可以在病变脑半球的多巴胺超敏纹状体中上调Syt-IV和P-物质(SP)mRNA,但不是D2受体。 D1-R介导的过敏反应可能是左旋多巴诱导的运动障碍的不良表达的元凶,这暗示了Syt-IV和SP参与该过程。首先,确定表达Syt-IV的纹状体细胞表型。发现它在所有纹状体神经元和少量星形胶质细胞中都有表达。然后检查,D1-R介导的Syt-IV mRNA的上调是否会导致翻译蛋白的上调。发现在用选择性D1激动剂急性刺激后,(+/-)-6-氯-7,8-二羟基-3-烯丙基-1-苯基-2,3,4,5-四氢-1H- 3-benzazepine氢溴酸盐(SKF-82958),Syt-IV在病变侧表达SP的纹状体神经元内升高。随后是直接通路中段多刺神经元的同侧目标核内的Syt-IV上调,但其mRNA却没有上调,表明从头合成的蛋白向其SP阳性突触末端的轴突转运。然而,尽管在相似的时间过程中SP和Syt-IV的纹状体上调,但未发现它们在轴突末端内的亚细胞共定位。因此,建议Syt-IV可能调节超敏纹状体突触传递,尽管是通过不依赖于SP的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号